Live RSS
Federal Grant · National Institutes of Health

Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)

Last verified by NonDilute: 2026-04-29. Official notice and agency instructions control.

AI/MLBiotechHealthcare Tech university-researcherindividual-researchersmall-team
The pitch

If you've built or are building generalizable genomics software or analytical methods, NIH will fund your continued development and refinement at scale.

Award range
Unspecified
Closes
Sep 7, 2027 · 496d left
Open date
Nov 18, 2024
Difficulty
Medium
Source
Grants.gov
Agency
National Institutes of Health
Last verified
2026-04-29
Fit language
Possible fit only
Apply at grants.gov →

Report stale or inaccurate summary

What this is

This NIH R21 grant funds innovative computational genomics and bioinformatics research that creates generalizable methods and tools applicable across the genomics community. Applicants can pursue fundamental research in analytical methodologies, develop early-stage software, or harden existing tools of value to biomedical researchers. The work must scale to large datasets and address broader human health questions rather than single-disease applications. Clinical trials are explicitly not allowed under this FOA.

Who can apply

Extremely broad eligibility: nonprofits with or without 501(c)(3) status, universities (public and private), small businesses, for-profit companies, government agencies, tribal organizations, and several others can apply. No geographic restriction mentioned. Solo researchers must be affiliated with an eligible organization.

Eligible applicant types

Full description — from the agency

The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease. This FOA supports fundamental genomics research developing innovative analytical methodologies and approaches, early-stage development of tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. Work supported under this FOA should be enabling for genomics and be generalizable or broadly applicable across diseases and biological systems. All applications should address how the methods would scale to address increasingly larger data sets.

Topics: computational genomics · bioinformatics tools · data science methods · genomic software development · statistical genomics · scalable analytics

Public-source funding discovery only. This summary is generated from public agency data and may be incomplete or stale. NonDilute is not affiliated with, endorsed by, or acting on behalf of any government agency. Official notices and agency instructions control. NonDilute does not determine eligibility, provide grant-writing advice, or guarantee funding.